Visby Medical IPO
Visby Medical develops portable PCR testing devices that deliver lab-quality diagnostic results in under 30 minutes at the point of care. The company's platform enables rapid testing for infectious diseases including COVID-19, flu, and sexually transmitted infections. Investors are interested in the growing point-of-care diagnostics market and the company's potential to transform rapid testing.
Key Facts
| Industry | Point-of-Care Diagnostics |
| Founded | 2012 |
| Headquarters | San Jose, CA |
| Employees | ~300 |
| Website | visbymedical.com |
| Funding | Series D raised $100M. Total raised: ~$200M |
About Visby Medical
Visby Medical develops portable PCR diagnostic devices that deliver lab-quality molecular testing results in under 30 minutes at the point of care. The company's single-use test cartridges and compact analyzer system enable healthcare providers to conduct molecular diagnostics for sexually transmitted infections and other conditions without requiring specialized laboratory facilities or technical expertise.
The company gained significant attention during the COVID-19 pandemic for its rapid molecular testing capabilities and has expanded its test menu to include multiple STI panels. Visby's technology aims to address the gap between rapid antigen tests, which are fast but less accurate, and traditional PCR tests, which are highly accurate but require centralized labs and longer turnaround times. The platform is particularly valuable in urgent care settings, pharmacies, and other decentralized healthcare environments.
IPO Status
Visby Medical has not announced any plans for an initial public offering. The company has raised significant venture funding to develop and commercialize its rapid PCR testing platform, but remains privately held. The diagnostics industry has seen increased investor interest following the COVID-19 pandemic, with several testing companies going public. However, Visby Medical has not provided any public timeline or indication regarding IPO plans. The company appears focused on expanding its product portfolio and market reach as a private company.
Competitors
Frequently Asked Questions
Does Visby Medical have a stock?
No, Visby Medical has not had an IPO and remains a privately held company. The company has not announced any plans to go public at this time.
When is the Visby Medical IPO date?
There is no confirmed IPO date for Visby Medical, as the company has not announced plans to go public. Any timeline for a potential IPO remains speculative.
How can I buy Visby Medical stock?
You cannot buy Visby Medical stock as it is not publicly traded. The company remains privately held and its shares are not available on public stock exchanges.
Stay Updated on the Visby Medical IPO
Get real-time alerts when Visby Medical files for an IPO, prices shares, or begins trading.
Get IPO Alerts